Onyx Biotec Share price
ONYX
36.5
3.45 (-8.64%)Last updated on 20 Feb, 2026 | 11:28 IST
Today's High
36.50
Today's Low
36.50
52 Week Low
28.10
52 Week High
62.45
Free Demat with Zero AMC*
Onyx Biotec Chart
Onyx Biotec Share Key Metrics
Volume
2000.00
Market Cap
72.44 CR
LTQ@LTP
2000@36.50
ATP
36.5
Var Margin
100 %
Circuit Range
32-47.9
Delivery %
93.75 %
Value
73000.00
ASM/GSM
No
Market Lot
2000
Summary
Onyx Biotec Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
63.82
Sector P/B
2.76
Sec. Div. Yield
0.57
Onyx Biotec Resistance and Support
Pivot 38.82
Resistance
First Resistance
41.09
Second Resistance
42.22
Third Resistance
44.49
Support
First Support
37.69
Second Support
35.42
Third Support
34.29
Onyx Biotec Corporate Actions
| Date | Agenda | |||
|---|---|---|---|---|
 | ||||
Onyx Biotec News
Onyx Biotec shares list at 11% discount below IPO price on NSE SME
Nov 22 2024 10:21:50
Onyx Biotec shares list at 11% discount below IPO price on NSE SME
Nov 22 2024 10:16:50
Onyx Biotec shares debut at 11% discount on NSE SME platform today
Nov 22 2024 11:31:54
About Onyx Biotec
NSE : 27136
BSE : 0
ISIN : INE0WVU01018
Our Company was incorporated on May 13 2005 as a private limited company as ‘Onyx Biotec Private Limited’ under the Companies Act 1956 pursuant to a certificate of incorporation dated May 13 2005 issued by the Registrar of Companies Punjab H.P. & Chandigarh. Further our Company was converted into a public limited company pursuant to a resolution passed by our Board of Directors in its meeting held on May 1 2024 and by the Shareholders in an Extraordinary General Meeting held on May 27 2024 and consequently the name of our Company was changed to ‘Onyx Biotec Limited’ and a fresh certificate of incorporation dated July 23 2024 was issued by the Registrar of Companies Central Processing Centre. The corporate identification number of our Company is U24230HP2005PLC028403.Major Events and Milestones:2010-Our Company commenced commercial production at our Unit I with two line of Form Fill and Seal setup with capacity of 2 lacs units per day2017-Capacity expansion at our Unit I from 130 million unit per annum to 230 million units per annum-Our Company received a certificate for Good Manufacturing Practice from Deputy Drugs Controller cum Licensing Authority Health & Family2023-Our Company commenced commercial production at our Unit II
Onyx Biotec Management
| Name | Position |
|---|---|
| Mr. Sanjay Jain | Managing Director |
| Mr. Harsh Mahajan | Whole Time Director |
Onyx Biotec Similar Stocks
Onyx Biotec FAQs
